BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu X, Tao Y, Shan L, Chen R, Jiang H, Qian Z, Cai F, Ma L, Yu Y. The Role of MicroRNAs in Hepatocellular Carcinoma. J Cancer 2018;9:3557-69. [PMID: 30310513 DOI: 10.7150/jca.26350] [Cited by in Crossref: 57] [Cited by in F6Publishing: 83] [Article Influence: 14.3] [Reference Citation Analysis]
Number Citing Articles
1 Yang J, Dong W, Zhang H, Zhao H, Zeng Z, Zhang F, Li Q, Duan X, Hu Y, Xiao W. Exosomal microRNA panel as a diagnostic biomarker in patients with hepatocellular carcinoma. Front Cell Dev Biol 2022;10:927251. [DOI: 10.3389/fcell.2022.927251] [Reference Citation Analysis]
2 Luo X, Wang Y, Zhang X, Liu W, Shi Z. The Clinical Value of Long Noncoding RNA DDX11-AS1 as a Biomarker for the Diagnosis and Prognosis of Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-8. [DOI: 10.1155/2022/5735462] [Reference Citation Analysis]
3 Wu Q, Wang L, Tsui SK. Mutational signatures representative transcriptomic perturbations in hepatocellular carcinoma. Front Genet 2022;13:970907. [DOI: 10.3389/fgene.2022.970907] [Reference Citation Analysis]
4 Zelli V, Compagnoni C, Capelli R, Corrente A, Di Vito Nolfi M, Zazzeroni F, Alesse E, Tessitore A. Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma. Front Oncol 2022;12:940056. [DOI: 10.3389/fonc.2022.940056] [Reference Citation Analysis]
5 Badami E, Busà R, Douradinha B, Russelli G, Miceli V, Gallo A, Zito G, Conaldi PG, Iannolo G. Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches. World J Gastroenterol 2022; 28(22): 2417-2428 [DOI: 10.3748/wjg.v28.i22.2417] [Reference Citation Analysis]
6 Zhang D, Liao X. Pan-TRK Immunohistochemistry and NTRK Gene Fusions in Primary Carcinomas of the Liver. Appl Immunohistochem Mol Morphol 2022. [PMID: 35587529 DOI: 10.1097/PAI.0000000000001032] [Reference Citation Analysis]
7 Khare S, Khare T, Ramanathan R, Ibdah JA. Hepatocellular Carcinoma: The Role of MicroRNAs. Biomolecules 2022;12:645. [DOI: 10.3390/biom12050645] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 El-Mahdy HA, Sallam AM, Ismail A, Elkhawaga SY, Elrebehy MA, Doghish AS. miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers. Pathol Res Pract 2022;233:153886. [PMID: 35405621 DOI: 10.1016/j.prp.2022.153886] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Lei Y, Chen L, Liu J, Zhong Y, Deng L. The MicroRNA-Based Strategies to Combat Cancer Chemoresistance via Regulating Autophagy. Front Oncol 2022;12:841625. [PMID: 35211417 DOI: 10.3389/fonc.2022.841625] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Xie Z, Zhong C, Duan S. miR-1269a and miR-1269b: Emerging Carcinogenic Genes of the miR-1269 Family. Front Cell Dev Biol 2022;10:809132. [DOI: 10.3389/fcell.2022.809132] [Reference Citation Analysis]
11 De Simone S, Giacani E, Bosco MA, Vittorio S, Ferrara M, Bertozzi G, Cipolloni L, La Russa R. The Role of miRNAs as New Molecular Biomarkers for Dating the Age of Wound Production: A Systematic Review. Front Med (Lausanne) 2021;8:803067. [PMID: 35096893 DOI: 10.3389/fmed.2021.803067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Si L, Yang Z, Ding L, Zhang D. Regulatory effects of lncRNAs and miRNAs on the crosstalk between autophagy and EMT in cancer: a new era for cancer treatment. J Cancer Res Clin Oncol 2022. [PMID: 35083552 DOI: 10.1007/s00432-021-03892-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Zheng T, Zhang X, Wang Y, Wang A. SPOCD1 regulated by miR-133a-3p promotes hepatocellular carcinoma invasion and metastasis. J Int Med Res 2022;50:030006052110537. [DOI: 10.1177/03000605211053717] [Reference Citation Analysis]
14 Khashkhashi Moghadam S, Bakhshinejad B, Khalafizadeh A, Mahmud Hussen B, Babashah S. Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma. J Cell Mol Med 2021. [PMID: 34907642 DOI: 10.1111/jcmm.17126] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Evangelista J, Zaninotto E, Gaglio A, Ghidini M, Raimondi L. MicroRNAs as Diagnostic Tools in Hepatocellular Carcinoma. GastrointestDisord 2021;3:237-46. [DOI: 10.3390/gidisord3040022] [Reference Citation Analysis]
16 Nguyen VT, Le TTK, Than K, Tran DH. Predicting miRNA-disease associations using improved random walk with restart and integrating multiple similarities. Sci Rep 2021;11:21071. [PMID: 34702958 DOI: 10.1038/s41598-021-00677-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Xu J, Zhang Y, Liu C, Yan P, Yang Z. Roles of the miR-139-5p/CCT5 axis in hepatocellular carcinoma: a bioinformatic analysis. Int J Med Sci 2021;18:3556-64. [PMID: 34522182 DOI: 10.7150/ijms.57504] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Zaker SR, Ghaedi K. Downregulation of LINC02615 Is Correlated with The Breast Cancer Progress: A Novel Biomarker for Differential Identification of Breast Cancer Tissues. Cell J 2021;23:414-20. [PMID: 34455716 DOI: 10.22074/cellj.2021.7283] [Reference Citation Analysis]
19 Ge Y, Gu P, Wang W, Cao L, Zhang L, Li J, Mu W, Wang H. Benzo[a]pyrene stimulates miR-650 expression to promote the pathogenesis of fatty liver disease and hepatocellular carcinoma via SOCS3/JAK/STAT3 cascades. J Mol Cell Biol 2021:mjab052. [PMID: 34450627 DOI: 10.1093/jmcb/mjab052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Azevedo A, Farinha D, Geraldes C, Faneca H. Combining gene therapy with other therapeutic strategies and imaging agents for cancer theranostics. Int J Pharm 2021;606:120905. [PMID: 34293466 DOI: 10.1016/j.ijpharm.2021.120905] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Dawood AA, Saleh AA, Elbahr O, Gohar SF, Habieb MS. Inverse relationship between the level of miRNA 148a-3p and both TGF-β1 and FIB-4 in hepatocellular carcinoma. Biochem Biophys Rep 2021;27:101082. [PMID: 34355070 DOI: 10.1016/j.bbrep.2021.101082] [Reference Citation Analysis]
22 Rebouissou S, Nault JC. Advances in molecular classification and precision oncology in hepatocellular carcinoma. J Hepatol 2020;72:215-29. [PMID: 31954487 DOI: 10.1016/j.jhep.2019.08.017] [Cited by in Crossref: 65] [Cited by in F6Publishing: 132] [Article Influence: 65.0] [Reference Citation Analysis]
23 Ohtsuka M, Iwamoto K, Naito A, Imasato M, Hyuga S, Nakahara Y, Mikamori M, Furukawa K, Moon J, Asaoka T, Kishi K, Shamma A, Akamatsu H, Mizushima T, Yamamoto H. Circulating MicroRNAs in Gastrointestinal Cancer. Cancers (Basel) 2021;13:3348. [PMID: 34283058 DOI: 10.3390/cancers13133348] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Moon H, Ro SW. MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma. Cancers (Basel) 2021;13:3026. [PMID: 34204242 DOI: 10.3390/cancers13123026] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
25 Yang X, Sun J, Sun H, Wen B, Zhang M, An H, Chen W, Zhao W, Zhong X, He C, Pang J, He S. MicroRNA-30a-3p acts as a tumor suppressor in MHCC-97H hepatocellular carcinoma cells by targeting COX-2. J Cancer 2021;12:3945-57. [PMID: 34093801 DOI: 10.7150/jca.52298] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
26 Singh A, Shafi S, Upadhyay T, Najmi AK, Kohli K, Pottoo FH. Insights into Nanotherapeutic Strategies as an Impending Approach to Liver Cancer Treatment. Curr Top Med Chem 2020;20:1839-54. [PMID: 32579503 DOI: 10.2174/1568026620666200624161801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Yalçınkaya B, Güzel E, Taştekin D, Pençe S. Role of mir-33a, mir-203b, mir361-3p, and mir-424 in hepatocellular carcinoma. Turk J Med Sci 2021;51:638-43. [PMID: 33098283 DOI: 10.3906/sag-2004-214] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
28 Huo X, Zhou H, Li T, Xu Z. MicroRNA-4325 Suppresses Cell Progression in Hepatocellular Carcinoma via GATA-Binding Protein 6. BioMed Research International 2021;2021:1-9. [DOI: 10.1155/2021/6616982] [Reference Citation Analysis]
29 Wang Q, Wang G, Xu X, Chen Z. miR-760 mediated the proliferation and metastasis of hepatocellular carcinoma cells by regulating HMGA2. Pathol Res Pract 2021;222:153420. [PMID: 33887625 DOI: 10.1016/j.prp.2021.153420] [Reference Citation Analysis]
30 Li FY, Fan TY, Zhang H, Sun YM. Demethylation of miR-34a upregulates expression of membrane palmitoylated proteins and promotes the apoptosis of liver cancer cells. World J Gastroenterol 2021; 27(6): 470-486 [PMID: 33642822 DOI: 10.3748/wjg.v27.i6.470] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Chen E, Li E, Liu H, Zhou Y, Wen L, Wang J, Wang Y, Ye L, Liang T. miR-26b enhances the sensitivity of hepatocellular carcinoma to Doxorubicin via USP9X-dependent degradation of p53 and regulation of autophagy. Int J Biol Sci 2021;17:781-95. [PMID: 33767588 DOI: 10.7150/ijbs.52517] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
32 Fawzy MS, Toraih EA. MicroRNA signatures as predictive biomarkers in transarterial chemoembolization‐treated hepatocellular carcinoma. Precision Medical Sciences 2021;10:4-14. [DOI: 10.1002/prm2.12031] [Reference Citation Analysis]
33 Zhou J, Cui X, Xiao F, Cai G. A Cluster-Based Approach for Identifying Prognostic microRNA Signatures in Digestive System Cancers. Int J Mol Sci 2021;22:1529. [PMID: 33546390 DOI: 10.3390/ijms22041529] [Reference Citation Analysis]
34 Semaan L, Zeng Q, Lu Y, Zhang Y, Zreik MM, Chamseddine MB, Chopp M, Zhang ZG, Moonka D. MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugs. Oncotarget 2021;12:185-98. [PMID: 33613846 DOI: 10.18632/oncotarget.27879] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
35 Yokota Y, Noda T, Okumura Y, Kobayashi S, Iwagami Y, Yamada D, Tomimaru Y, Akita H, Gotoh K, Takeda Y, Tanemura M, Murakami T, Umeshita K, Doki Y, Eguchi H. Serum exosomal miR-638 is a prognostic marker of HCC via downregulation of VE-cadherin and ZO-1 of endothelial cells. Cancer Sci 2021;112:1275-88. [PMID: 33426736 DOI: 10.1111/cas.14807] [Cited by in Crossref: 2] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
36 You LN, Tai QW, Xu L, Hao Y, Guo WJ, Zhang Q, Tong Q, Zhang H, Huang WK. Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma. Cancer Gene Ther 2021;28:719-36. [PMID: 33414518 DOI: 10.1038/s41417-020-00269-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
37 Najm M, Sadaf, Shingatgeri V, Saha H, Bhattacharya H, Rath A, Verma V, Gupta A, Aloliqi A, Kashyap P, Parveen F. Hippo pathway in cancer: Examining its potential. J Curr Oncol 2021;4:115. [DOI: 10.4103/jco.jco_9_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Bortolami M, Comparato A, Benna C, Errico A, Maretto I, Pucciarelli S, Cillo U, Farinati F. Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and "normal" liver tissues. PLoS One 2020;15:e0244356. [PMID: 33362215 DOI: 10.1371/journal.pone.0244356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Wang H, Ellipilli S, Lee WJ, Li X, Vieweger M, Ho YS, Guo P. Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance. J Control Release 2021;330:173-84. [PMID: 33316298 DOI: 10.1016/j.jconrel.2020.12.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
40 Sun DS, Guan CH, Wang WN, Hu ZT, Zhao YQ, Jiang XM. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis. Microvasc Res 2021;134:104120. [PMID: 33309645 DOI: 10.1016/j.mvr.2020.104120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
41 Bai ZZ, Li HY, Li CH, Sheng CL, Zhao XN. M1 Macrophage-Derived Exosomal MicroRNA-326 Suppresses Hepatocellular Carcinoma Cell Progression Via Mediating NF-κB Signaling Pathway. Nanoscale Res Lett 2020;15:221. [PMID: 33263825 DOI: 10.1186/s11671-020-03432-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 18] [Article Influence: 0.5] [Reference Citation Analysis]
42 Kumar S, Reddy PH. A New Discovery of MicroRNA-455-3p in Alzheimer's Disease. J Alzheimers Dis 2019;72:S117-30. [PMID: 31524168 DOI: 10.3233/JAD-190583] [Cited by in Crossref: 15] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
43 Nia A, Dhanasekaran R. Genomic Landscape of HCC. Curr Hepatol Rep 2020;19:448-61. [PMID: 33816052 DOI: 10.1007/s11901-020-00553-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
44 Zhu Z, Shen S, Zhao S, Wang Z. Hsa_circ_0006916 Knockdown Represses the Development of Hepatocellular Carcinoma via Modulating miR-599/SRSF2 Axis. Onco Targets Ther 2020;13:11301-13. [PMID: 33177838 DOI: 10.2147/OTT.S267471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Caviglia GP, Ciruolo M, Abate ML, Carucci P, Rolle E, Rosso C, Olivero A, Troshina G, Risso A, Nicolosi A, Ribaldone DG, Armandi A, Tandoi F, Saracco GM, Bugianesi E, Ciancio A, Gaia S. Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology. Cancers (Basel) 2020;12:E3218. [PMID: 33142893 DOI: 10.3390/cancers12113218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
46 Xia F, Xia W, Yu X. LncRNA HOTAIR Influences the Growth, Migration, and Invasion of Papillary Thyroid Carcinoma via Affection on the miR-488-5p/NUP205 Axis. Technol Cancer Res Treat 2020;19:1533033820962125. [PMID: 33107391 DOI: 10.1177/1533033820962125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
47 Zhang Z, Tan X, Luo J, Yao H, Si Z, Tong JS. The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma. Cell Death Dis 2020;11:902. [PMID: 33097691 DOI: 10.1038/s41419-020-03123-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
48 Zhong D, Lyu X, Fu X, Xie P, Liu M, He F, Huang G. Upregulation of miR-124-3p by Liver X Receptor Inhibits the Growth of Hepatocellular Carcinoma Cells Via Suppressing Cyclin D1 and CDK6. Technol Cancer Res Treat 2020;19:1533033820967473. [PMID: 33073697 DOI: 10.1177/1533033820967473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Chen FR, Wang Y, Cheng Y, Shi HT, Li H, Jia M, Sha SM, Dong L. The AC006262.5-miR-7855-5p-BPY2C axis facilitates hepatocellular carcinoma proliferation and migration. Biochem Cell Biol 2021;99:348-55. [PMID: 32956593 DOI: 10.1139/bcb-2019-0239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
50 Gao W, Chen X, Chi W, Xue M. Long non‑coding RNA MKLN1‑AS aggravates hepatocellular carcinoma progression by functioning as a molecular sponge for miR‑654‑3p, thereby promoting hepatoma‑derived growth factor expression. Int J Mol Med 2020;46:1743-54. [PMID: 33000222 DOI: 10.3892/ijmm.2020.4722] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
51 Jing Y, Liang W, Liu J, Zhang L, Wei J, Yang J, Zhang Y, Huang Z. Autophagy-mediating microRNAs in cancer chemoresistance. Cell Biol Toxicol 2020;36:517-36. [PMID: 32875398 DOI: 10.1007/s10565-020-09553-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
52 Xu J, An P, Winkler CA, Yu Y. Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets. Front Oncol. 2020;10:1271. [PMID: 32850386 DOI: 10.3389/fonc.2020.01271] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
53 Wu J, Huang WJ, Xi HL, Liu LY, Wang ST, Fan WZ, Peng BG. Tumor-suppressive miR-3650 inhibits tumor metastasis by directly targeting NFASC in hepatocellular carcinoma. Aging (Albany NY) 2019;11:3432-44. [PMID: 31163018 DOI: 10.18632/aging.101981] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
54 Marin JJG, Macias RIR, Monte MJ, Romero MR, Asensio M, Sanchez-Martin A, Cives-Losada C, Temprano AG, Espinosa-Escudero R, Reviejo M, Bohorquez LH, Briz O. Molecular Bases of Drug Resistance in Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E1663. [PMID: 32585893 DOI: 10.3390/cancers12061663] [Cited by in Crossref: 22] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
55 Ma W, Cui Y, Liu M, Tan Z, Jiang Y. Downregulation of miR-125b promotes resistance of glioma cells to TRAIL through overexpression of Tafazzin which is a mitochondrial protein. Aging (Albany NY) 2019;11:2670-80. [PMID: 31056533 DOI: 10.18632/aging.101939] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
56 Deng X, Chen Y, Liu Z, Xu J. MiR-124-3p.1 Sensitizes Ovarian Cancer Cells to Mitochondrial Apoptosis Induced by Carboplatin. Onco Targets Ther 2020;13:5375-86. [PMID: 32606755 DOI: 10.2147/OTT.S242342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
57 Cheng Y, Liu N, Yang C, Jiang J, Zhao J, Zhao G, Chen F, Zhao H, Li Y. MicroRNA-383 inhibits proliferation, migration, and invasion in hepatocellular carcinoma cells by targeting PHF8. Mol Genet Genomic Med 2020;8:e1272. [PMID: 32441881 DOI: 10.1002/mgg3.1272] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
58 Yamashita H, Surapureddi S, Kovi RC, Bhusari S, Ton TV, Li JL, Shockley KR, Peddada SD, Gerrish KE, Rider CV, Hoenerhoff MJ, Sills RC, Pandiri AR. Unique microRNA alterations in hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice. Arch Toxicol 2020;94:2523-41. [PMID: 32306082 DOI: 10.1007/s00204-020-02749-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Gao S, Hu W, Huang X, Huang X, Chen W, Hao L, Chen Z, Wang J, Wei H. Circ_0001178 regulates miR-382/VEGFA axis to facilitate hepatocellular carcinoma progression. Cell Signal 2020;72:109621. [PMID: 32240747 DOI: 10.1016/j.cellsig.2020.109621] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
60 Iacob DG, Rosca A, Ruta SM. Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis. World J Gastroenterol 2020; 26(11): 1113-1127 [PMID: 32231417 DOI: 10.3748/wjg.v26.i11.1113] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
61 Hu M, Fu Q, Jing C, Zhang X, Qin T, Pan Y. LncRNA HOTAIR knockdown inhibits glycolysis by regulating miR-130a-3p/HIF1A in hepatocellular carcinoma under hypoxia. Biomed Pharmacother. 2020;125:109703. [PMID: 32062551 DOI: 10.1016/j.biopha.2019.109703] [Cited by in Crossref: 15] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
62 Zhao H, Xie Z, Tang G, Wei S, Chen G. Knockdown of terminal differentiation induced ncRNA (TINCR) suppresses proliferation and invasion in hepatocellular carcinoma by targeting the miR-218-5p/DEAD-box helicase 5 (DDX5) axis. J Cell Physiol 2020;235:6990-7002. [PMID: 31994189 DOI: 10.1002/jcp.29595] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
63 Yuan P, Yang T, Mu J, Zhao J, Yang Y, Yan Z, Hou Y, Chen C, Xing J, Zhang H, Li J. Circadian clock gene NPAS2 promotes reprogramming of glucose metabolism in hepatocellular carcinoma cells. Cancer Letters 2020;469:498-509. [DOI: 10.1016/j.canlet.2019.11.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
64 Meroni M, Longo M, Erconi V, Valenti L, Gatti S, Fracanzani AL, Dongiovanni P. mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance. Nutrients 2019;11:E2597. [PMID: 31671785 DOI: 10.3390/nu11112597] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
65 Zhang Q, Zhu B, Qian J, Wang K, Zhou J. miR-942 promotes proliferation and metastasis of hepatocellular carcinoma cells by inhibiting RRM2B. Onco Targets Ther 2019;12:8367-78. [PMID: 31632084 DOI: 10.2147/OTT.S207549] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
66 Santhekadur PK, Kumar DP. RISC assembly and post-transcriptional gene regulation in Hepatocellular Carcinoma. Genes Dis 2020;7:199-204. [PMID: 32215289 DOI: 10.1016/j.gendis.2019.09.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
67 Huang XB, He YG, Zheng L, Feng H, Li YM, Li HY, Yang FX, Li J. Identification of hepatitis B virus and liver cancer bridge molecules based on functional module network. World J Gastroenterol 2019; 25(33): 4921-4932 [PMID: 31543683 DOI: 10.3748/wjg.v25.i33.4921] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
68 Wang S, Wang W, Han X, Wang Y, Ge Y, Tan Z. Dysregulation of miR484-TUSC5 axis takes part in the progression of hepatocellular carcinoma. J Biochem 2019;166:271-9. [PMID: 31157375 DOI: 10.1093/jb/mvz034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
69 Yue C, Liang C, Ge H, Yan L, Xu Y, Li G, Wu J. SUCO as a Promising Diagnostic Biomarker of Hepatocellular Carcinoma: Integrated Analysis and Experimental Validation. Med Sci Monit 2019;25:6292-303. [PMID: 31434866 DOI: 10.12659/MSM.915262] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
70 Shehab-Eldeen S, Nada A, Abou-Elela D, El-Naidany S, Arafat E, Omar T. Diagnostic Performance of microRNA-122 and microRNA-224 in Hepatitis C Virus-Induced Hepatocellular Carcinoma (HCC). Asian Pac J Cancer Prev 2019;20:2515-22. [PMID: 31450927 DOI: 10.31557/APJCP.2019.20.8.2515] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
71 Zhao L, Wang Y, Liu Q. Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p/MTA3 signalling in hepatocellular carcinoma. Experimental and Molecular Pathology 2019;109:51-60. [DOI: 10.1016/j.yexmp.2019.104265] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
72 Li C, Yu S, Wu S, Ni Y, Pan Z. MicroRNA-936 targets FGF2 to inhibit epithelial ovarian cancer aggressiveness by deactivating the PI3K/Akt pathway. Onco Targets Ther 2019;12:5311-22. [PMID: 31371979 DOI: 10.2147/OTT.S213231] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
73 Qiu L, Wang T, Ge Q, Xu H, Wu Y, Tang Q, Chen K. Circular RNA Signature in Hepatocellular Carcinoma. J Cancer 2019;10:3361-72. [PMID: 31293639 DOI: 10.7150/jca.31243] [Cited by in Crossref: 26] [Cited by in F6Publishing: 37] [Article Influence: 8.7] [Reference Citation Analysis]
74 Zhang F, Yang C, Xing Z, Liu P, Zhang B, Ma X, Huang L, Zhuang L. LncRNA GAS5-mediated miR-1323 promotes tumor progression by targeting TP53INP1 in hepatocellular carcinoma. Onco Targets Ther 2019;12:4013-23. [PMID: 31190897 DOI: 10.2147/OTT.S209439] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
75 Xiao C, Pan C, Liu E, He H, Liu C, Huang Y, Yi S, Huang D. Differences of microRNA expression profiles between monozygotic twins' blood samples. Forensic Sci Int Genet 2019;41:152-8. [PMID: 31132533 DOI: 10.1016/j.fsigen.2019.05.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
76 Yang Q, Zhang L, Zhong Y, Lai L, Li X. miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma. Biosci Rep 2019;39:BSR20181823. [PMID: 31048362 DOI: 10.1042/BSR20181823] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
77 Pu J, Wang J, Xu Z, Lu Y, Wu X, Wu Y, Shao Z, Tang Q, Wei H. miR-632 Functions as Oncogene in Hepatocellular Carcinoma via Targeting MYCT1. Hum Gene Ther Clin Dev 2019;30:67-73. [PMID: 30982352 DOI: 10.1089/humc.2019.040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
78 Zappavigna S, Vanacore D, Lama S, Potenza N, Russo A, Ferranti P, Dallio M, Federico A, Loguercio C, Sperlongano P, Caraglia M, Stiuso P. Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells. Int J Mol Sci 2019;20:E2190. [PMID: 31058823 DOI: 10.3390/ijms20092190] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
79 Ren W, Wu S, Wu Y, Liu T, Zhao X, Li Y. MicroRNA-196a/-196b regulate the progression of hepatocellular carcinoma through modulating the JAK/STAT pathway via targeting SOCS2. Cell Death Dis 2019;10:333. [PMID: 30988277 DOI: 10.1038/s41419-019-1530-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
80 Li Y, Chen F, Chu J, Wu C, Li Y, Li H, Ma H. miR-148-3p Inhibits Growth of Glioblastoma Targeting DNA Methyltransferase-1 (DNMT1). Oncol Res 2019;27:911-21. [PMID: 30982493 DOI: 10.3727/096504019X15516966905337] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
81 Han Y. Analysis of the role of the Hippo pathway in cancer. J Transl Med 2019;17:116. [PMID: 30961610 DOI: 10.1186/s12967-019-1869-4] [Cited by in Crossref: 60] [Cited by in F6Publishing: 96] [Article Influence: 20.0] [Reference Citation Analysis]
82 Xue Y, Yang X, Hu S, Kang M, Chen J, Fang Y. A genetic variant in miR-100 is a protective factor of childhood acute lymphoblastic leukemia. Cancer Med 2019;8:2553-60. [PMID: 30848099 DOI: 10.1002/cam4.2082] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
83 Yue C, Ren Y, Ge H, Liang C, Xu Y, Li G, Wu J. Comprehensive analysis of potential prognostic genes for the construction of a competing endogenous RNA regulatory network in hepatocellular carcinoma. Onco Targets Ther 2019;12:561-76. [PMID: 30679912 DOI: 10.2147/OTT.S188913] [Cited by in Crossref: 22] [Cited by in F6Publishing: 36] [Article Influence: 7.3] [Reference Citation Analysis]